Evidence map›Paper›PMID 34622373›Full record

ReviewCurrent urology reports2021

Robotic-Assisted Partial Nephrectomy: Techniques to Improve Clinical Outcomes.

P Macek, X Cathelineau, Y P Barbe, R Sanchez-Salas, A R Rodriguez

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current urology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

P MacekDepartment of Urology, Institute Montsouris, 42 Boulevard Jourdan, 75014, Paris, France. petr.macek@imm.fr.ORCID http://orcid.org/0000-0002-9021-7072
X CathelineauDepartment of Urology, Institute Montsouris, 42 Boulevard Jourdan, 75014, Paris, France.ORCID http://orcid.org/0000-0003-3928-1543
Y P BarbeDepartment of Urology, Institute Montsouris, 42 Boulevard Jourdan, 75014, Paris, France.ORCID http://orcid.org/0000-0002-3437-409X
R Sanchez-SalasDepartment of Urology, Institute Montsouris, 42 Boulevard Jourdan, 75014, Paris, France.ORCID http://orcid.org/0000-0003-2407-4760
A R RodriguezRochester General Hospital, Rochester, NY, USA.ORCID http://orcid.org/0000-0001-8954-153X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo summarize current options available for robot-assisted partial nephrectomy RECENT

findingsPartial nephrectomy (PN) is a standard treatment option for management of cT1 renal masses. It may be carried out by multiple approaches. Robot-assisted (RA) PN is one such option. The goal of treatment is both correct oncological (negative surgical margins) and functional (preservation of sufficient amount of renal parenchyma of the operated kidney) outcome. Appropriate outcomes depend on multiple factors. There are many, but among others tumor characteristics (size, location, i.e., tumor complexity), patient baseline renal function, patient comorbidities, and performance status etc. Based on all these, the surgeon adapts the intervention for each mass/patient by preoperative planning, absence/use/duration of warm or cold ischemia, perioperative imaging, resection technique adapted to tumor location and depth of invasion, use of hemostatics, type and degree of renal parenchymal closure and others details. Nephroprotective agents have not shown efficacy so far. It should not be forgotten that surgeon's experience plays a key role in the achievement of good results. Although multiple factors have a role in the RA partial nephrectomy, surgeon experience and adaptation of technique of intervention have the crucial role in the achievement of both functional and oncological results.

Indexed as

Kidney NeoplasmsLaparoscopyRobotic Surgical ProceduresHumansNephrectomyTreatment OutcomeIschemiaPartial nephrectomyRenalResultsTumor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.